Lee Scott Golden Sells $88K of PTC Therapeutics Inc (PTCT) — SEC Form 4, Feb 21, 2025
Open-Market Net Sale · SEC Form 4
−$88,045
10b5-1 Plan
Equity position changed by -2.2%
Equity Position
76.9K sh
78,651 → 76,894
Equity Change
-2.2%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Lee Scott Golden CIK 0001686217 |
EVP
|
Lee Scott Golden at PTC Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,081,515
More from this insider at PTC Therapeutics Inc
| 2026-04-06 | Sell | -$56,364 | View |
| 2026-03-09 | Sell | -$633,800 | View |
| 2026-02-20 | Sell | -$172,290 | View |
| 2026-01-12 | Sell | -$66,206 | View |
| 2026-01-08 | Sell | -$152,855 | View |
Non-Derivative Securities Transactions
Footnotes (1)
- F1
- Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 5,000 RSUs from a February 15, 2024 grant of 20,000 RSUs and the vesting of 1,300 RSUs from a February 15, 2024 grant of 2,600 RSUs. Show more
Related filings at PTC Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
384
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $1.14B
- Rtw Investments, Lp $632M
- Jupiter Topco Llc $590M
5%+ Holders · 13D/G
5 filers
Other insiders at PTC Therapeutics Inc
-
Michael Schmertzler -$149K
-
Mark Elliott Boulding -$12.3K
-
Michael Schmertzler -$158K
-
Mark Elliott Boulding -$133K
-
Md Steele Glenn Phd Jr -$782K
GET /v1/forms/4/0001415889-25-005135
API docs
View Original SEC Filing